SEARCH

SEARCH BY CITATION

References

  • 1
    European Lung White Book. The first comprehensive survey on respiratory health in Europe. In: LoddenkemperR, GibsonGJ, SybilleY, editors. European Respiratory Society. Sheffield: ERSJ, 2003:1625.
  • 2
    Bousquet J, Khaltaev N. Global surveillance, prevention and control of Chronic Respiratory Diseases. A comprehensive approach. Global Alliance against Chronic Respiratory Diseases. ISBN 978 92 4 156346 8. World Health Organization, 2007:148.
  • 3
    Bousquet J, Burney PG, Zuberbier T, Cauwenberge PV, Akdis CA, Bindslev-Jensen C et al. GA2LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma ‘epidemic’. Allergy 2009;64:969977.
  • 4
    Van WeelC, Bateman ED, Bousquet J, Reid J, Grouse L, Schermer T et al. Asthma management pocket reference 2008. Allergy 2008;63:9971004.
  • 5
    Global strategy for asthma management and prevention. GINA report. http://www.ginasthma.com (Accessed December 2008).
  • 6
    Stupka E, DeShazo R. Asthma in seniors. Part 1. Evidence for underdiagnosis, undertreatment, and increasing morbidity and mortality. Am J Med 2009;122:611.
  • 7
    Reindal L, Øymar K. Hospital admissions for wheezing and asthma in childhood – are they avoidable? J Asthma 2006;43:801806.
  • 8
    Karadag B, Karakoc F, Ersu R, Dagli E. Is childhood asthma still underdiagnosed and undertreated in Istanbul? Pediatr Int 2007;49:508512.
  • 9
    Yeh KW, Chiang LC, Huang JL. Epidemiology and current status of asthma and associated allergic diseases in Taiwan – ARIA Asia-Pacific Workshop Report. Asian Pac J Allergy Immunol 2008;26:257264.
  • 10
    Martins P, Rosado-Pinto J, Do Céu Teixeira M, Neuparth N, Silva O, Tavares H et al. Under-report and underdiagnosis of chronic respiratory diseases in an African country. Allergy 2009;64:10611067.
  • 11
    Von Hertzen LC, Haahtela T. Asthma and atopy – the price of affluence? Allergy 2004;59:124137.
  • 12
    Von Hertzen LC, Haahtela T. Disconnection of man and the soil: reason for the asthma and atopy epidemic? J Allergy Clin Immunol 2006;117:334344.
  • 13
    Von Hertzen L, Laatikainen T, Pitkänen T, Vlasoff T, Mäkelä MJ, Vartiainen E et al. Microbial content of drinking water in Finish and Russian Karelia – implications for atopy prevalence. Allergy 2007;62:288292.
  • 14
    Stelmach I, Smejda K, Jerzynska J, Stelmach W, Majak P, Stelmach P et al. Decreased markers of atopy in children with presumed early exposure to allergens, unhygienic conditions, and infections. Ann Allergy Asthma Immunol 2007;99:170177.
  • 15
    Von Hertzen L, Haahtela T. Signs of reversing trends of asthma. Allergy 2005;60:283292.
  • 16
    Haahtela T, Laitinen LA. Asthma programme in Finland 1994–2004. Report of a Working Group. Clin Exp Allergy 1996; 26(Suppl. 1):124.
  • 17
    Haahtela T, Klaukka T, Koskela K, Erhola M, Laitinen LA. Asthma programme in Finland: a community problems needs community solutions. Thorax 2001;56:806814.
  • 18
    Haahtela T, Tuomisto LE, Pietinalho A, Klaukka T, Erhola M, Kaila M et al. A 10 year asthma programme in Finland: major change for the better. Thorax 2006;61:663670.
  • 19
    Reissel E, Herse F, Väänänen J, Karjalainen J, Klaukka T, Haahtela T. Astman hinta Suomessa 1987–2005 – pitkäaikaissairauden hoidon kustannukset ja taloudelliset hyödyt (Asthma costs in Finland) (in Finnish). Fin Med J, in press.
  • 20
    Haahtela T, Von Hertzen L, Mäkelä M et al. Finish Allergy Programme 2008–2018 – time to act and change the course. Allergy 2008;63:634645.
  • 21
    Liebhart J, Malolepszy J, Wojtyniak B, Pisiewicz K, Plusa T, Gladysz U. Polish Multicentre Study of Epidemiology of Allergic Diseases. Prevalence and risk factors for asthma in Poland: results from the PMSEAD study. J Investig Allergol Clin Immunol 2007;17:367374.
  • 22
    Kuprys-Lipinska I, Elgalal A, Kuna P. Underdiagnosis and undertreatment of asthma in general population of Lodz province (Poland). Pneumonol Alergol Pol 2009, in press.
  • 23
    Kupczyk M, Kuprys I, Gorski P, Kuna P. Long term deterioration of lung function in asthmatic outpatients. Respiration 2004;71:233240.
  • 24
    Kupczyk M, Kuprys I, Gorski P, Kuna P. Aspirin intolerance and allergy to house dust mites: important factors associated with development of severe asthma. Ann Allergy Asthma Immunol 2004;92:453458.
  • 25
    Stelmach I, Jerzynska J, Stelmach W, Majak P, Chew G, Gorski P et al. Cockroach allergy and exposure to cockroach allergen in Polish children with asthma. Allergy 2002;57:701705.
  • 26
    Kowalski ML, Jędrzejczak M, Cirlić M. Efektywność leczenia astmy oskrzelowej w Polsce w ocenie pacjentów – wyniki badania AIRCEE (The efficacy of bronchial asthma therapy in Poland in the estimation of the patients themselves – results of the AIRCEE study) (Asthma Insights & Reality in Central and Eastern Europe)(in Polish). Alergia Astma Immunologia 2004;9:187195.
  • 27
    Stelmach W, Majak P, Jerzynska J, Stelmach I. Early effects of Asthma Prevention Program on asthma diagnosis and hospitalization in urban population of Poland. Allergy 2005;60:606610.
  • 28
    Kuna P, Kupczyk M, Kupryś-Lipińska I. POLASTMA – National Programme of Early Diagnostics and Treatment of Asthma. ISBN 978-83-929380-1-9; http://www.mojaastma.org.pl/files/polastma_en.pdf; 2009: 32.
  • 29
    Asher MI, Montefort S, Bjorksten B, Lai CK, Strachan DP, Weiland SK et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006;368:733743.
  • 30
    Sembajwe G, Cifuentes M, Tak S, Kriebel D, Gore R, Punnett L. National income, self-reported wheezing and asthma diagnosis from the World Health Survey. Eur Respir J; DOI: 10.1183/09031936.00027509.
  • 31
    Solé D, Camelo-Nunes IC, Wandalsen GF, Mallozi MC, Naspitz CK, Brazilian ISAAC’s Group. Is the prevalence of asthma and related symptoms among Brazilian children related to socioeconomic status? J Asthma 2008;45:1925.
  • 32
    Franco R, Nascimento HF, Cruz AA, Santos AC, Souza-Machado C, Ponte EV et al. The economic impact of severe asthma to low-income families. Allergy 2009;64:478483.
  • 33
    Cruz AA, Bousquet PJ. The unbearable cost of severe asthma in underprivileged populations. Allergy 2009;64:319321.
  • 34
    Franco R, Santos AC, Nascimento HF, Souza-Machado C, Ponte E, Souza-Machado A et al. Cost-effectiveness analysis of a state funded programme for control of sever asthma. BMC Public Health 2007;7:8289.
  • 35
    Brasil, Ministério da Saúde. Secretaria de Atenção à Saúde. Available at: http://www.datasus.gov.br/cnesnet/tabnet.htm (Accessed 25 May 2009).
  • 36
    Adachi M, Ohta K, Morikawa A, Nishima S, Tokunaga S, Disantostefano RL. Changes in asthma insights and reality in Japan (AIRJ) in 2005 since 2000. Arerugi 2008;57:107120.
  • 37
    Boulet LP, Dorval E, Labrecque M, Turgeon M, Montague T, Thivierge RL. Towards Excellence in Asthma Management: final report of an eight-year program aimed at reducing care gaps in asthma management in Quebec. Can Respir J 2008;15:302310 (Review).
  • 38
    McCaul KA, Wakefield MA, Roder DM, Ruffin RE, Heard AR, Alpers JH et al. Trends in hospital readmission for asthma: has the Australian National Asthma Campaign had an effect? Med J Aust 2000;172:6266.
  • 39
    Foliaki S, Fakakovikaetau T, D’Souza W, Latu S, Tutone V, Cheng S et al. Reduction in asthma morbidity following a community-based asthma self-management programme in Tonga. Int J Tuberc Lung Dis 2009;13:142147.
  • 40
    Bousquet J, Dahl R, Khaltaev N. Global Alliance against Chronic Respiratory Diseases. Eur Respir J 2007;29:233239.
  • 41
    World Health Organization. Practical Approach to Lung Health (PAL). Manual on initiating PAL implementation. Geneva: World Health Organization, 2008.